FDA Inspection 1209086 — Biocon Pharma Limited
The FDA completed an inspection of Biocon Pharma Limited on June 2, 2023 in Bengaluru. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 2, 2023
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Bengaluru (India)